多模态影像在非感染性后葡萄膜炎中临床效用的系统评价:MUV项目报告3
该系统评价检索OVID MEDLINE、Embase、Cochrane和Scopus,纳入2018年至2024年的70项研究及2012至2017年的63项基础研究,基于6537例患者的影像检查汇总292条影像学陈述和124条临床效用陈述,其中OCT或OCTA占66/124(53%)。结论认为非感染性后葡萄膜炎影像学发现信息丰富,专家意见普遍支持多模态影像的临床效用,但需进一步研究并考虑修订现行分类指南。
要点
- OCT在每种疾病的至少一项结局指标上证据等级为高,其次为CFP、FAF和FA在5种疾病中的4种(80%),OCTA在3/5(60%),ICGA在1/5(20%)。
- 124条临床效用陈述中OCT或OCTA占66/124(53%),另有29条关于多模态影像的临床效用陈述。
- 专家意见普遍支持多模态影像的临床效用,但需进一步研究并考虑修订现行分类指南。
核心结论
- 非感染性后葡萄膜炎影像学发现已有大量信息,专家意见普遍支持多模态影像的临床效用。
- 需要进一步开展采用高效影像策略和客观结局指标的研究,并应考虑修订现行分类指南。
研究设计与样本
- 系统评价,在OVID MEDLINE、Embase、Cochrane和Scopus中进行同行评议电子检索,最后检索日期为2024年8月6日。
- 主要分析纳入2018年1月1日至2024年7月12日发表的医学文献,次要分析纳入2012至2017年(含)的文献。
- 由独立评价者使用Covidence系统评价工具提取数据,使用混合方法评估工具评估质量和偏倚,随后进行共识流程。
- 主要分析纳入70项符合纳入标准和研究类型质量标准的2018-2024年研究,结合63项2012-2017年基础研究,基于6537例患者的影像检查汇总292条具体影像学陈述。
- 使用GRADE流程评价证据等级,方案在PROSPERO注册(CRD42024576867)。
主要发现
- 主要分析基于6537例患者的影像检查得出292条具体影像学陈述,并汇总124条临床效用陈述。
- 124条临床效用陈述中,OCT或OCTA占66/124(53%),另有29条关于多模态影像的临床效用陈述。
- OCT在每种疾病的至少一项结局指标上证据等级为高。
- 证据等级为高的比例:CFP、FAF和FA在5种疾病中的4种(80%),OCTA在3/5(60%),ICGA在1/5(20%)。
关键数值与推荐
- 影像学发现覆盖的疾病包括:急性后极部多灶性鳞状色素上皮病变(APMPPE)、鸟枪弹样脉络膜视网膜病变、多灶性脉络膜炎、点状内层脉络膜病变、多灶性一过性白点综合征(MEWDS)和匐行性脉络膜炎。
- 影像模态包括彩色眼底照相(CFP)、自发荧光(FAF)、OCT、荧光素血管造影(FA)、吲哚菁绿血管造影(ICGA)和OCT血管成像(OCTA)。
- 临床效用陈述涉及诊断、活动性检测、监测或并发症检测。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步开展采用高效影像策略和客观结局指标的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TOPIC: The clinical utility of multimodal imaging for diagnosis and management of non-infectious posterior uveitis. RELEVANCE: Advances in multimodal imaging support amendment of the imaging strategies in the authoritative classification criteria published by the Standards of Uveitis Nomenclature II in 2021. METHODS: Peer-reviewed electronic search in OVID MEDLINE, Embase, Cochrane, Scopus, last accessed August 6, 2024. Medical literature published from January 1, 2018, to July 12, 2024, for the primary analysis and from 2012-2017 inclusive for the secondary analysis. Independent reviewers extracted data using the Covidence Systematic Review Tool and assessed quality and bias with the Mixed Methods Assessment Tool, followed by a consensus process. Statements of imaging findings and clinical utility were tabulated. Main outcome measures were: (1) factual imaging findings for acute posterior multifocal placoid pigment epitheliopathy (APMPPE), birdshot chorioretinitis, multifocal choroiditis, punctate inner choroidopathy, multifocal evanescent white dot syndrome (MEWDS) and serpiginous choroiditis. Imaging modalities included color fundus (CFP), autofluorescence (FAF), OCT, fluorescein angiography (FA), indocyanine green angiography (ICGA) and OCT angiography; (2) subjective or objective statements of clinical utility for diagnosis, detection of activity, monitoring, or detection of complications. The level of evidence was evaluated using the GRADE process. RESULTS: 70 studies from 2018-2024 met inclusion criteria and quality standards for study type. Combined with 63 foundational studies from 2012-2017, there were 292 specific imaging statements based on imaging examinations of 6537 patients in the primary analysis. There were 124 statements of clinical utility, with OCT or OCTA accounting for 66/124 (53%), plus an additional 29 statements of clinical utility for multimodal imaging (MMI). Evidence was ranked high for OCT on at least one outcome measure for each disease, followed by CFP, FAF, and FA in 4 of 5 diseases (80%), OCTA in 3 of 5 (60%), and ICGA in 1 of 5 (20%). CONCLUSION: Substantial information exists regarding the imaging findings in noninfectious posterior uveitis. Expert opinions generally favor the clinical utility of MMI. Additional research with efficient imaging strategies and objective outcome measures is warranted. Revision of current classification guidelines should be considered. OTHER: Protocol registration CRD42024576867 with PROSPERO (https://crd.york.ac.uk/prospero/).
引用
- Accorinti M, Berkenstock MK, Cicinelli MV, et al. Systematic Review of Clinical Utility of Multimodal Imaging in Noninfectious Posterior Uveitis: MUV Project Report 3. Am J Ophthalmol. 2025. PMID: 40659111. doi:10.1016/j.ajo.2025.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。